163 related articles for article (PubMed ID: 24418683)
1. First-morning urinary melatonin and breast cancer risk in the Guernsey Study.
Wang XS; Tipper S; Appleby PN; Allen NE; Key TJ; Travis RC
Am J Epidemiol; 2014 Mar; 179(5):584-93. PubMed ID: 24418683
[TBL] [Abstract][Full Text] [Related]
2. Melatonin and breast cancer: a prospective study.
Travis RC; Allen DS; Fentiman IS; Key TJ
J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
[TBL] [Abstract][Full Text] [Related]
3. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743
[TBL] [Abstract][Full Text] [Related]
4. Urinary Melatonin in Relation to Breast Cancer Risk: Nested Case-Control Analysis in the DOM Study and Meta-analysis of Prospective Studies.
Wong ATY; Fensom GK; Key TJ; Onland-Moret NC; Tong TYN; Travis RC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):97-103. PubMed ID: 33144281
[TBL] [Abstract][Full Text] [Related]
5. Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.
Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Yu MC
Int J Cancer; 2013 Feb; 132(4):891-6. PubMed ID: 22644618
[TBL] [Abstract][Full Text] [Related]
6. Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.
Sturgeon SR; Doherty A; Reeves KW; Bigelow C; Stanczyk FZ; Ockene JK; Liu S; Manson JE; Neuhouser ML
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):629-37. PubMed ID: 24510738
[TBL] [Abstract][Full Text] [Related]
7. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.
Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES
Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174
[TBL] [Abstract][Full Text] [Related]
8. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort.
Schernhammer ES; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):74-9. PubMed ID: 19124483
[TBL] [Abstract][Full Text] [Related]
9. Urinary melatonin and risk of ovarian cancer.
Poole EM; Schernhammer E; Mills L; Hankinson SE; Tworoger SS
Cancer Causes Control; 2015 Oct; 26(10):1501-6. PubMed ID: 26223889
[TBL] [Abstract][Full Text] [Related]
10. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
[No Abstract] [Full Text] [Related]
11. Urinary melatonin levels and breast cancer risk.
Schernhammer ES; Hankinson SE
J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
[TBL] [Abstract][Full Text] [Related]
12. A nested case-control study of the association between melatonin secretion and incident myocardial infarction.
McMullan CJ; Rimm EB; Schernhammer ES; Forman JP
Heart; 2017 May; 103(9):694-701. PubMed ID: 27806988
[TBL] [Abstract][Full Text] [Related]
13. Sleep duration, nightshift work, and the timing of meals and urinary levels of 8-isoprostane and 6-sulfatoxymelatonin in Japanese women.
Nagata C; Tamura T; Wada K; Konishi K; Goto Y; Nagao Y; Ishihara K; Yamamoto S
Chronobiol Int; 2017; 34(9):1187-1196. PubMed ID: 28933565
[TBL] [Abstract][Full Text] [Related]
14. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women.
McMullan CJ; Curhan GC; Schernhammer ES; Forman JP
Am J Epidemiol; 2013 Jul; 178(2):231-8. PubMed ID: 23813704
[TBL] [Abstract][Full Text] [Related]
15. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
[TBL] [Abstract][Full Text] [Related]
16. Disruption of sleep, sleep-wake activity rhythm, and nocturnal melatonin production in breast cancer patients undergoing adjuvant chemotherapy: prospective cohort study.
Li W; Kwok CC; Chan DC; Ho AW; Ho CS; Zhang J; Wing YK; Wang F; Tse LA
Sleep Med; 2019 Mar; 55():14-21. PubMed ID: 30743205
[TBL] [Abstract][Full Text] [Related]
17. Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.
Pérez-Caraballo AM; Ma Y; Ockene JK; Reeves KW; Balasubramanian R; Stanczyk FZ; Allison MA; Chen C; Wang L; Manson JE; Sturgeon SR
Chronobiol Int; 2018 Aug; 35(8):1115-1121. PubMed ID: 29750588
[TBL] [Abstract][Full Text] [Related]
18. Melatonin secretion and the incidence of type 2 diabetes.
McMullan CJ; Schernhammer ES; Rimm EB; Hu FB; Forman JP
JAMA; 2013 Apr; 309(13):1388-96. PubMed ID: 23549584
[TBL] [Abstract][Full Text] [Related]
19. Exploratory assessment of pineal gland volume, composition, and urinary 6-sulfatoxymelatonin levels on prostate cancer risk.
Bazzi LA; Sigurdardottir LG; Sigurdsson S; Valdimarsdottir U; Torfadottir J; Aspelund T; Czeisler CA; Lockley SW; Jonsson E; Launer L; Harris T; Gudnason V; Mucci LA; Markt SC
Prostate; 2021 Jun; 81(8):487-496. PubMed ID: 33860950
[TBL] [Abstract][Full Text] [Related]
20. Morning urinary assessment of nocturnal melatonin secretion in older women.
Cook MR; Graham C; Kavet R; Stevens RG; Davis S; Kheifets L
J Pineal Res; 2000 Jan; 28(1):41-7. PubMed ID: 10626600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
